BioCatalyst

HROW — HARROW, INC. catalysts

1 verified catalyst event(s) for HARROW, INC. (ticker HROW). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Propar · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3%
Phase 4 · Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD)
 HROW HARROW, INC. Chloroprocaine Ophthalmic Gel 3% (IHEEZO ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.